avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSMUSG00000005677.15 | Nr1i3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1i3 | mm39_v1_chr1_+_171041583_171041612 | 0.69 | 3.2e-06 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_63262775 | 24.91 |
ENSMUST00000030044.3
|
Orm1
|
orosomucoid 1 |
chr4_-_61437704 | 24.63 |
ENSMUST00000095051.6
ENSMUST00000107483.8 |
Mup16
|
major urinary protein 16 |
chr7_+_26819334 | 24.42 |
ENSMUST00000003100.10
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr9_+_46179899 | 22.95 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr15_+_76579960 | 21.75 |
ENSMUST00000229679.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr4_+_115156243 | 21.63 |
ENSMUST00000084343.4
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr17_-_46749370 | 20.69 |
ENSMUST00000087012.7
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr17_-_33136277 | 20.46 |
ENSMUST00000234538.2
ENSMUST00000235058.2 ENSMUST00000234759.2 ENSMUST00000179434.8 ENSMUST00000234797.2 |
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr15_+_76579885 | 20.35 |
ENSMUST00000231028.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr4_-_61259997 | 20.04 |
ENSMUST00000071005.9
ENSMUST00000075206.12 |
Mup14
|
major urinary protein 14 |
chr4_-_62005498 | 18.56 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr4_-_60222580 | 18.54 |
ENSMUST00000095058.5
ENSMUST00000163931.8 |
Mup8
|
major urinary protein 8 |
chr5_-_145816774 | 18.21 |
ENSMUST00000035918.8
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr9_-_46146558 | 17.70 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr3_-_81883509 | 17.22 |
ENSMUST00000029645.14
ENSMUST00000193879.2 |
Tdo2
|
tryptophan 2,3-dioxygenase |
chr8_+_105652867 | 16.78 |
ENSMUST00000034355.11
ENSMUST00000109410.4 |
Ces2e
|
carboxylesterase 2E |
chr5_-_145946408 | 16.48 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr19_+_12610668 | 16.07 |
ENSMUST00000044976.12
|
Glyat
|
glycine-N-acyltransferase |
chr4_-_60457902 | 16.06 |
ENSMUST00000084548.11
ENSMUST00000103012.10 ENSMUST00000107499.4 |
Mup1
|
major urinary protein 1 |
chr17_+_84990541 | 15.85 |
ENSMUST00000045714.15
ENSMUST00000171915.2 |
Abcg8
|
ATP binding cassette subfamily G member 8 |
chr6_+_41279199 | 15.85 |
ENSMUST00000031913.5
|
Try4
|
trypsin 4 |
chr4_-_60618357 | 15.84 |
ENSMUST00000084544.5
ENSMUST00000098046.10 |
Mup11
|
major urinary protein 11 |
chr4_-_60538151 | 15.76 |
ENSMUST00000098047.3
|
Mup10
|
major urinary protein 10 |
chr4_+_115375461 | 15.59 |
ENSMUST00000058785.10
ENSMUST00000094886.4 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr4_+_63280675 | 14.93 |
ENSMUST00000075341.4
|
Orm2
|
orosomucoid 2 |
chr4_-_60777462 | 14.88 |
ENSMUST00000211875.2
|
Mup22
|
major urinary protein 22 |
chr4_-_61592331 | 14.82 |
ENSMUST00000098040.4
|
Mup18
|
major urinary protein 18 |
chr10_+_128089965 | 14.67 |
ENSMUST00000060782.5
ENSMUST00000218722.2 |
Apon
|
apolipoprotein N |
chr10_-_127843377 | 14.52 |
ENSMUST00000219447.2
ENSMUST00000219780.2 ENSMUST00000219707.2 ENSMUST00000219953.2 ENSMUST00000219183.2 |
Hsd17b6
|
hydroxysteroid (17-beta) dehydrogenase 6 |
chr9_+_46180362 | 14.15 |
ENSMUST00000214202.2
ENSMUST00000215458.2 ENSMUST00000215187.2 ENSMUST00000213878.2 ENSMUST00000034584.4 |
Apoa5
|
apolipoprotein A-V |
chr2_+_58645189 | 13.74 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr6_+_121815473 | 13.51 |
ENSMUST00000032228.9
|
Mug1
|
murinoglobulin 1 |
chr9_-_46146928 | 13.04 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr1_-_130589321 | 13.03 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr2_+_102536701 | 12.79 |
ENSMUST00000123759.8
ENSMUST00000005220.11 ENSMUST00000111212.8 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr14_-_34077340 | 12.59 |
ENSMUST00000052126.6
|
Fam25c
|
family with sequence similarity 25, member C |
chr11_+_69945157 | 12.54 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr10_+_127702326 | 12.14 |
ENSMUST00000092058.4
|
Rdh16f2
|
RDH16 family member 2 |
chr6_-_55152002 | 12.12 |
ENSMUST00000003569.6
|
Inmt
|
indolethylamine N-methyltransferase |
chr4_-_63072367 | 12.10 |
ENSMUST00000030041.5
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr7_-_105249308 | 12.08 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr4_-_61972348 | 11.84 |
ENSMUST00000074018.4
|
Mup20
|
major urinary protein 20 |
chr6_+_90527762 | 11.81 |
ENSMUST00000130418.8
ENSMUST00000032175.11 ENSMUST00000203111.2 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr1_-_130589349 | 11.72 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr2_+_172994841 | 11.55 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr17_-_56428968 | 11.45 |
ENSMUST00000041357.9
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1 |
chr6_-_5256282 | 11.41 |
ENSMUST00000031773.9
|
Pon3
|
paraoxonase 3 |
chr5_+_146016064 | 11.39 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr1_+_72863641 | 11.38 |
ENSMUST00000047328.11
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr4_-_60070411 | 11.31 |
ENSMUST00000079697.10
ENSMUST00000125282.2 ENSMUST00000166098.8 |
Mup7
|
major urinary protein 7 |
chr4_-_60697274 | 11.28 |
ENSMUST00000117932.2
|
Mup12
|
major urinary protein 12 |
chr6_+_42222841 | 11.20 |
ENSMUST00000031897.8
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr17_-_84990360 | 11.16 |
ENSMUST00000066175.10
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr15_+_82338247 | 11.14 |
ENSMUST00000230000.2
|
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr10_+_87695352 | 11.13 |
ENSMUST00000121952.8
ENSMUST00000126490.8 |
Igf1
|
insulin-like growth factor 1 |
chr7_-_140856642 | 11.00 |
ENSMUST00000080654.7
ENSMUST00000167263.9 |
Cdhr5
|
cadherin-related family member 5 |
chr4_-_61259801 | 10.96 |
ENSMUST00000125461.8
|
Mup14
|
major urinary protein 14 |
chr4_-_60139857 | 10.86 |
ENSMUST00000107490.5
ENSMUST00000074700.9 |
Mup2
|
major urinary protein 2 |
chr9_-_57590926 | 10.65 |
ENSMUST00000034860.5
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr2_+_121978156 | 10.55 |
ENSMUST00000102476.5
|
B2m
|
beta-2 microglobulin |
chr7_-_19432129 | 10.55 |
ENSMUST00000172808.2
ENSMUST00000174191.2 |
Apoe
|
apolipoprotein E |
chr10_+_87357657 | 10.51 |
ENSMUST00000020241.17
|
Pah
|
phenylalanine hydroxylase |
chr4_+_115268821 | 10.51 |
ENSMUST00000094887.4
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr6_-_85846110 | 10.51 |
ENSMUST00000045008.8
|
Nat8f2
|
N-acetyltransferase 8 (GCN5-related) family member 2 |
chr10_+_87357782 | 10.50 |
ENSMUST00000219813.2
|
Pah
|
phenylalanine hydroxylase |
chr1_-_139487951 | 10.40 |
ENSMUST00000023965.8
|
Cfhr1
|
complement factor H-related 1 |
chr15_+_10224052 | 10.27 |
ENSMUST00000128450.8
ENSMUST00000148257.8 ENSMUST00000128921.8 |
Prlr
|
prolactin receptor |
chr19_-_8109346 | 10.22 |
ENSMUST00000065651.5
|
Slc22a28
|
solute carrier family 22, member 28 |
chr9_-_15212849 | 10.19 |
ENSMUST00000034414.10
|
4931406C07Rik
|
RIKEN cDNA 4931406C07 gene |
chr17_-_31363245 | 10.12 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr16_-_17906886 | 9.95 |
ENSMUST00000132241.2
ENSMUST00000139861.2 ENSMUST00000003620.13 |
Prodh
|
proline dehydrogenase |
chr17_-_35077089 | 9.90 |
ENSMUST00000153400.8
|
Cfb
|
complement factor B |
chr3_-_18297451 | 9.78 |
ENSMUST00000035625.7
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr9_+_46151994 | 9.62 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr4_+_134123631 | 9.56 |
ENSMUST00000105869.9
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr1_-_140111138 | 9.51 |
ENSMUST00000111976.9
ENSMUST00000066859.13 |
Cfh
|
complement component factor h |
chr1_-_140111018 | 9.45 |
ENSMUST00000192880.6
ENSMUST00000111977.8 |
Cfh
|
complement component factor h |
chr2_-_25391729 | 9.39 |
ENSMUST00000015227.4
|
C8g
|
complement component 8, gamma polypeptide |
chr1_-_180021039 | 9.29 |
ENSMUST00000160482.8
ENSMUST00000170472.8 |
Coq8a
|
coenzyme Q8A |
chr16_-_18232202 | 9.23 |
ENSMUST00000165430.8
ENSMUST00000147720.3 |
Comt
|
catechol-O-methyltransferase |
chr19_+_38995463 | 9.17 |
ENSMUST00000025966.5
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr15_+_99291491 | 9.05 |
ENSMUST00000159531.3
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr15_+_99291455 | 9.01 |
ENSMUST00000162624.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr1_+_87998487 | 8.95 |
ENSMUST00000073772.5
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr6_+_90310252 | 8.94 |
ENSMUST00000046128.12
ENSMUST00000164761.6 |
Uroc1
|
urocanase domain containing 1 |
chr11_-_70910058 | 8.57 |
ENSMUST00000108523.10
ENSMUST00000143850.8 |
Derl2
|
Der1-like domain family, member 2 |
chr17_-_13159204 | 8.55 |
ENSMUST00000043923.12
|
Acat3
|
acetyl-Coenzyme A acetyltransferase 3 |
chr7_+_25597045 | 8.49 |
ENSMUST00000072438.13
ENSMUST00000005477.6 |
Cyp2b10
|
cytochrome P450, family 2, subfamily b, polypeptide 10 |
chr16_+_22739191 | 8.48 |
ENSMUST00000116625.10
|
Fetub
|
fetuin beta |
chr4_+_115458172 | 8.37 |
ENSMUST00000084342.6
|
Cyp4a32
|
cytochrome P450, family 4, subfamily a, polypeptide 32 |
chr16_-_18245352 | 8.33 |
ENSMUST00000000335.12
|
Comt
|
catechol-O-methyltransferase |
chr1_-_180021218 | 8.29 |
ENSMUST00000159914.8
|
Coq8a
|
coenzyme Q8A |
chr10_+_80165787 | 8.26 |
ENSMUST00000105358.8
ENSMUST00000105357.2 ENSMUST00000105354.8 ENSMUST00000105355.8 |
Reep6
|
receptor accessory protein 6 |
chr8_+_120163857 | 8.25 |
ENSMUST00000152420.8
ENSMUST00000212112.2 ENSMUST00000098365.4 |
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr14_+_14475188 | 8.22 |
ENSMUST00000026315.8
|
Dnase1l3
|
deoxyribonuclease 1-like 3 |
chr8_+_105460627 | 8.21 |
ENSMUST00000034346.15
ENSMUST00000164182.3 |
Ces2a
|
carboxylesterase 2A |
chr7_-_30672747 | 8.21 |
ENSMUST00000205961.2
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr10_+_128030315 | 8.15 |
ENSMUST00000044776.13
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr5_-_87240405 | 8.06 |
ENSMUST00000132667.2
ENSMUST00000145617.8 ENSMUST00000094649.11 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr3_-_107925159 | 7.96 |
ENSMUST00000004140.11
|
Gstm1
|
glutathione S-transferase, mu 1 |
chr15_-_34495329 | 7.87 |
ENSMUST00000022946.6
|
Rida
|
reactive intermediate imine deaminase A homolog |
chr7_-_30672824 | 7.85 |
ENSMUST00000147431.2
ENSMUST00000098553.11 ENSMUST00000108116.10 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr14_+_30608433 | 7.84 |
ENSMUST00000120269.11
ENSMUST00000078490.14 ENSMUST00000006703.15 |
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr4_-_141553306 | 7.84 |
ENSMUST00000102481.4
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr14_+_30608478 | 7.81 |
ENSMUST00000168782.4
|
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr10_-_127206300 | 7.78 |
ENSMUST00000026472.10
|
Inhbc
|
inhibin beta-C |
chr10_-_81127334 | 7.74 |
ENSMUST00000219479.2
|
Tjp3
|
tight junction protein 3 |
chr12_+_87193922 | 7.73 |
ENSMUST00000222885.2
|
Gstz1
|
glutathione transferase zeta 1 (maleylacetoacetate isomerase) |
chr7_-_30672889 | 7.69 |
ENSMUST00000001279.15
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr14_+_66208613 | 7.66 |
ENSMUST00000144619.2
|
Clu
|
clusterin |
chr1_-_51955126 | 7.55 |
ENSMUST00000046390.14
|
Myo1b
|
myosin IB |
chr16_+_13758494 | 7.55 |
ENSMUST00000141971.8
ENSMUST00000124947.8 ENSMUST00000023360.14 ENSMUST00000143697.8 |
Mpv17l
|
Mpv17 transgene, kidney disease mutant-like |
chr10_+_87357816 | 7.51 |
ENSMUST00000218573.2
|
Pah
|
phenylalanine hydroxylase |
chr17_-_79292856 | 7.51 |
ENSMUST00000118991.2
|
Prkd3
|
protein kinase D3 |
chr11_-_75313412 | 7.42 |
ENSMUST00000138661.8
ENSMUST00000000769.14 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr11_-_84058292 | 7.42 |
ENSMUST00000050771.8
|
Gm11437
|
predicted gene 11437 |
chr12_+_87194476 | 7.39 |
ENSMUST00000063117.10
ENSMUST00000220574.2 |
Gstz1
|
glutathione transferase zeta 1 (maleylacetoacetate isomerase) |
chr11_-_116089595 | 7.27 |
ENSMUST00000072948.11
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr12_-_103739847 | 7.26 |
ENSMUST00000078869.6
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr1_+_88066086 | 7.26 |
ENSMUST00000014263.6
|
Ugt1a6a
|
UDP glucuronosyltransferase 1 family, polypeptide A6A |
chr2_+_4923815 | 7.15 |
ENSMUST00000027975.8
|
Phyh
|
phytanoyl-CoA hydroxylase |
chr10_+_87697155 | 7.10 |
ENSMUST00000122100.3
|
Igf1
|
insulin-like growth factor 1 |
chr11_+_75358866 | 7.08 |
ENSMUST00000043598.14
ENSMUST00000108435.2 |
Tlcd2
|
TLC domain containing 2 |
chr4_+_140970161 | 7.04 |
ENSMUST00000138096.8
ENSMUST00000006618.9 ENSMUST00000125392.8 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr7_-_139682280 | 7.03 |
ENSMUST00000142105.8
|
Fuom
|
fucose mutarotase |
chr4_-_117992064 | 7.03 |
ENSMUST00000097912.8
ENSMUST00000030263.9 ENSMUST00000106410.8 |
St3gal3
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
chr12_-_72675624 | 7.02 |
ENSMUST00000208039.2
ENSMUST00000207585.2 |
Gm4756
|
predicted gene 4756 |
chr10_+_87695117 | 6.99 |
ENSMUST00000105300.9
|
Igf1
|
insulin-like growth factor 1 |
chr17_+_25097199 | 6.94 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr10_+_87695886 | 6.85 |
ENSMUST00000062862.13
|
Igf1
|
insulin-like growth factor 1 |
chr17_-_34962823 | 6.81 |
ENSMUST00000069507.9
|
C4b
|
complement component 4B (Chido blood group) |
chr1_+_166081755 | 6.78 |
ENSMUST00000194964.6
ENSMUST00000192638.6 ENSMUST00000192426.6 ENSMUST00000195557.6 ENSMUST00000192732.6 ENSMUST00000193860.2 |
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr4_-_137157824 | 6.78 |
ENSMUST00000102522.5
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr4_-_41503046 | 6.77 |
ENSMUST00000054920.5
|
Myorg
|
myogenesis regulating glycosidase (putative) |
chr17_+_35481702 | 6.77 |
ENSMUST00000172785.8
|
H2-D1
|
histocompatibility 2, D region locus 1 |
chr3_+_134986982 | 6.76 |
ENSMUST00000120397.8
ENSMUST00000029817.11 |
Bdh2
|
3-hydroxybutyrate dehydrogenase, type 2 |
chr19_-_8382424 | 6.76 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
chr13_-_42000958 | 6.75 |
ENSMUST00000072012.10
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr9_-_103097022 | 6.71 |
ENSMUST00000168142.8
|
Trf
|
transferrin |
chr4_-_63073028 | 6.71 |
ENSMUST00000142901.2
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr1_+_88093726 | 6.66 |
ENSMUST00000097659.5
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr5_+_137568086 | 6.59 |
ENSMUST00000198866.5
|
Tfr2
|
transferrin receptor 2 |
chr16_+_91066602 | 6.56 |
ENSMUST00000056882.7
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr5_-_87288177 | 6.52 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr13_-_42001075 | 6.47 |
ENSMUST00000179758.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr17_-_31852128 | 6.43 |
ENSMUST00000236909.2
|
Cbs
|
cystathionine beta-synthase |
chr9_-_51874846 | 6.43 |
ENSMUST00000034552.8
ENSMUST00000214013.2 |
Fdx1
|
ferredoxin 1 |
chr6_-_5256225 | 6.43 |
ENSMUST00000125686.8
|
Pon3
|
paraoxonase 3 |
chr18_-_56695259 | 6.39 |
ENSMUST00000171844.3
|
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr2_+_43445333 | 6.38 |
ENSMUST00000028223.9
ENSMUST00000112826.8 |
Kynu
|
kynureninase |
chr13_-_42001102 | 6.33 |
ENSMUST00000121404.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr15_-_96947963 | 6.33 |
ENSMUST00000230907.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr19_+_4036562 | 6.32 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr7_-_99345016 | 6.32 |
ENSMUST00000107086.9
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr13_+_4099001 | 6.24 |
ENSMUST00000118717.10
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr13_-_64277115 | 6.23 |
ENSMUST00000220792.2
ENSMUST00000222866.2 ENSMUST00000099441.6 ENSMUST00000222168.2 |
Slc35d2
|
solute carrier family 35, member D2 |
chr8_+_105573693 | 6.23 |
ENSMUST00000055052.6
|
Ces2c
|
carboxylesterase 2C |
chr7_+_26508305 | 6.21 |
ENSMUST00000040944.9
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr11_-_74816750 | 6.20 |
ENSMUST00000121738.8
|
Srr
|
serine racemase |
chr1_+_131725119 | 6.16 |
ENSMUST00000112393.9
ENSMUST00000048660.12 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr6_+_141575226 | 6.13 |
ENSMUST00000042812.9
|
Slco1b2
|
solute carrier organic anion transporter family, member 1b2 |
chr1_-_51955054 | 6.08 |
ENSMUST00000018561.14
ENSMUST00000114537.9 |
Myo1b
|
myosin IB |
chr1_+_4878046 | 6.08 |
ENSMUST00000027036.11
ENSMUST00000150971.8 ENSMUST00000119612.9 ENSMUST00000137887.8 ENSMUST00000115529.8 |
Lypla1
|
lysophospholipase 1 |
chr10_+_80165961 | 6.06 |
ENSMUST00000186864.7
ENSMUST00000040081.7 |
Reep6
|
receptor accessory protein 6 |
chr4_-_62069046 | 6.04 |
ENSMUST00000077719.4
|
Mup21
|
major urinary protein 21 |
chr3_+_94600863 | 6.02 |
ENSMUST00000090848.10
ENSMUST00000173981.8 ENSMUST00000173849.8 ENSMUST00000174223.2 |
Selenbp2
|
selenium binding protein 2 |
chr1_+_93062962 | 5.94 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr8_-_84738761 | 5.93 |
ENSMUST00000191523.2
ENSMUST00000190457.2 ENSMUST00000185457.2 |
Misp3
|
MISP family member 3 |
chr15_-_89258034 | 5.91 |
ENSMUST00000228977.2
|
Sco2
|
SCO2 cytochrome c oxidase assembly protein |
chr3_-_157630690 | 5.91 |
ENSMUST00000118539.2
|
Cth
|
cystathionase (cystathionine gamma-lyase) |
chr4_+_140688514 | 5.88 |
ENSMUST00000010007.9
|
Sdhb
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr6_-_48549594 | 5.88 |
ENSMUST00000009425.7
ENSMUST00000204267.3 ENSMUST00000204930.3 ENSMUST00000204182.2 |
Rarres2
|
retinoic acid receptor responder (tazarotene induced) 2 |
chr4_-_42756489 | 5.86 |
ENSMUST00000140546.3
ENSMUST00000102957.6 |
Ccl19
|
chemokine (C-C motif) ligand 19 |
chr4_-_107928567 | 5.80 |
ENSMUST00000106701.2
|
Scp2
|
sterol carrier protein 2, liver |
chr8_-_106660470 | 5.79 |
ENSMUST00000034368.8
|
Ctrl
|
chymotrypsin-like |
chr5_-_45607485 | 5.78 |
ENSMUST00000154962.8
ENSMUST00000118097.8 ENSMUST00000198258.5 |
Qdpr
|
quinoid dihydropteridine reductase |
chr10_-_78300802 | 5.77 |
ENSMUST00000041616.15
|
Pdxk
|
pyridoxal (pyridoxine, vitamin B6) kinase |
chr9_-_70859418 | 5.77 |
ENSMUST00000216798.2
|
Lipc
|
lipase, hepatic |
chr7_-_139682295 | 5.76 |
ENSMUST00000120034.8
ENSMUST00000121115.2 ENSMUST00000026539.14 |
Fuom
|
fucose mutarotase |
chr8_-_3517617 | 5.74 |
ENSMUST00000111081.10
ENSMUST00000004686.13 |
Pex11g
|
peroxisomal biogenesis factor 11 gamma |
chr13_-_55574596 | 5.73 |
ENSMUST00000021948.15
|
F12
|
coagulation factor XII (Hageman factor) |
chr15_-_89258012 | 5.72 |
ENSMUST00000167643.4
|
Sco2
|
SCO2 cytochrome c oxidase assembly protein |
chr6_-_21851827 | 5.70 |
ENSMUST00000202353.2
ENSMUST00000134635.2 ENSMUST00000123116.8 ENSMUST00000120965.8 ENSMUST00000143531.2 |
Tspan12
|
tetraspanin 12 |
chr18_-_56695333 | 5.70 |
ENSMUST00000066208.13
ENSMUST00000172734.8 |
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr7_+_65511482 | 5.68 |
ENSMUST00000176199.8
|
Pcsk6
|
proprotein convertase subtilisin/kexin type 6 |
chr13_-_55574582 | 5.67 |
ENSMUST00000170921.2
|
F12
|
coagulation factor XII (Hageman factor) |
chr9_+_22365586 | 5.66 |
ENSMUST00000168332.2
|
Gm17545
|
predicted gene, 17545 |
chr6_-_3988835 | 5.65 |
ENSMUST00000203257.2
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr15_+_10314173 | 5.64 |
ENSMUST00000127467.3
|
Prlr
|
prolactin receptor |
chr6_-_3988900 | 5.64 |
ENSMUST00000183682.3
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr5_+_115604321 | 5.60 |
ENSMUST00000145785.8
ENSMUST00000031495.11 ENSMUST00000112071.8 ENSMUST00000125568.2 |
Pla2g1b
|
phospholipase A2, group IB, pancreas |
chr10_+_128030500 | 5.59 |
ENSMUST00000123291.2
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr11_+_101258368 | 5.56 |
ENSMUST00000019469.3
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr4_+_135648041 | 5.54 |
ENSMUST00000030434.5
|
Fuca1
|
fucosidase, alpha-L- 1, tissue |
chr12_-_81014849 | 5.53 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr12_-_81014755 | 5.51 |
ENSMUST00000218342.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr7_+_43874752 | 5.50 |
ENSMUST00000075162.5
|
Klk1
|
kallikrein 1 |
chr2_+_71811526 | 5.48 |
ENSMUST00000090826.12
ENSMUST00000102698.10 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr11_+_78389913 | 5.44 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chr2_+_105054657 | 5.43 |
ENSMUST00000068813.3
|
Them7
|
thioesterase superfamily member 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 39.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
9.6 | 28.7 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
9.5 | 28.5 | GO:0009073 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
8.1 | 24.4 | GO:0018931 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
7.9 | 23.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
7.7 | 30.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
6.6 | 39.9 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
4.6 | 32.1 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
4.5 | 17.8 | GO:0046226 | coumarin catabolic process(GO:0046226) |
4.4 | 8.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
4.0 | 15.9 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
3.9 | 11.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
3.8 | 11.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
3.7 | 29.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
3.7 | 25.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
3.6 | 18.1 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
3.5 | 10.6 | GO:1904438 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
3.5 | 10.5 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
3.5 | 17.6 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
3.3 | 26.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
3.1 | 12.3 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
3.1 | 30.8 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
2.8 | 42.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.8 | 8.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
2.7 | 15.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.5 | 22.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.4 | 17.1 | GO:0015886 | heme transport(GO:0015886) |
2.4 | 28.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.4 | 7.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
2.4 | 7.1 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
2.4 | 2.4 | GO:0002476 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
2.3 | 2.3 | GO:1900141 | regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) |
2.3 | 13.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.2 | 11.1 | GO:0006548 | histidine catabolic process(GO:0006548) |
2.2 | 11.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
2.2 | 11.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.1 | 12.9 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
2.1 | 6.3 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
2.1 | 10.3 | GO:1904970 | brush border assembly(GO:1904970) |
2.1 | 12.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.0 | 18.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.0 | 5.9 | GO:0042853 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) oxalic acid secretion(GO:0046724) |
2.0 | 11.8 | GO:0008355 | olfactory learning(GO:0008355) |
1.9 | 5.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.9 | 5.8 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.9 | 13.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.8 | 5.4 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
1.8 | 9.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.8 | 3.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.7 | 25.9 | GO:0015747 | urate transport(GO:0015747) |
1.7 | 5.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.7 | 1.7 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
1.7 | 6.8 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.6 | 6.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.6 | 21.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.5 | 15.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.5 | 6.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.5 | 9.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.5 | 45.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.5 | 7.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.5 | 4.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.5 | 10.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
1.4 | 5.8 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
1.4 | 4.3 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.4 | 13.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.3 | 5.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.3 | 4.0 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
1.3 | 3.9 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
1.3 | 7.9 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.3 | 3.9 | GO:0019405 | alditol catabolic process(GO:0019405) |
1.3 | 6.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.3 | 3.8 | GO:0043181 | vacuolar sequestering(GO:0043181) |
1.3 | 3.8 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.3 | 6.3 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.3 | 7.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.2 | 6.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.2 | 16.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.2 | 3.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.2 | 3.6 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
1.2 | 3.6 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
1.2 | 6.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
1.2 | 2.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
1.2 | 14.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.2 | 4.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.2 | 3.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
1.1 | 11.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.1 | 3.4 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
1.1 | 6.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.1 | 8.9 | GO:0071569 | protein ufmylation(GO:0071569) |
1.1 | 12.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.1 | 5.5 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.1 | 4.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
1.1 | 2.2 | GO:0045818 | negative regulation of glycogen catabolic process(GO:0045818) |
1.1 | 1.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.1 | 4.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.1 | 6.4 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
1.1 | 12.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
1.1 | 6.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.1 | 59.1 | GO:0006953 | acute-phase response(GO:0006953) |
1.0 | 5.2 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
1.0 | 4.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.0 | 7.2 | GO:0060309 | elastin catabolic process(GO:0060309) |
1.0 | 5.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.0 | 2.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.0 | 6.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.0 | 2.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
1.0 | 5.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.0 | 6.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 1.0 | GO:1901080 | regulation of relaxation of smooth muscle(GO:1901080) positive regulation of relaxation of smooth muscle(GO:1901082) |
1.0 | 5.0 | GO:0070178 | D-serine metabolic process(GO:0070178) |
1.0 | 2.9 | GO:0006507 | GPI anchor release(GO:0006507) protein depalmitoleylation(GO:1990697) |
1.0 | 5.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
1.0 | 4.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.0 | 3.8 | GO:0015755 | fructose transport(GO:0015755) |
1.0 | 2.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.9 | 0.9 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.9 | 4.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.9 | 4.6 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.9 | 3.7 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.9 | 2.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.9 | 8.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.9 | 5.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.9 | 16.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.9 | 3.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.9 | 1.8 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.9 | 6.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.8 | 3.4 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 3.4 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.8 | 2.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 4.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.8 | 3.3 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.8 | 1.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.8 | 4.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.8 | 22.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.8 | 4.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.8 | 2.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.8 | 1.6 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.8 | 1.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.8 | 5.5 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.8 | 17.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.8 | 1.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 4.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 9.8 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.8 | 3.0 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.7 | 6.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.7 | 3.0 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.7 | 2.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.7 | 3.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.7 | 2.9 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.7 | 2.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.7 | 1.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.7 | 3.5 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.7 | 4.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 2.0 | GO:0019085 | early viral transcription(GO:0019085) |
0.7 | 4.0 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.7 | 2.6 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.7 | 15.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.7 | 8.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.7 | 28.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.7 | 2.6 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.6 | 6.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 4.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.6 | 1.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.6 | 1.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.6 | 1.9 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.6 | 2.5 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.6 | 3.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 13.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.6 | 0.6 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.6 | 0.6 | GO:0002465 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) |
0.6 | 1.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.6 | 3.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 0.6 | GO:1903413 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
0.6 | 1.8 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.6 | 4.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 6.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 1.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 1.8 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.6 | 4.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 7.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 5.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.6 | 2.3 | GO:0044108 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.6 | 1.7 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
0.6 | 2.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.6 | 1.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.6 | 3.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.6 | 5.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.6 | 20.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.6 | 3.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.6 | 1.7 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.5 | 1.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 0.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.5 | 3.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.5 | 37.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 2.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.5 | 2.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.5 | 2.7 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.5 | 2.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.5 | 2.1 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.5 | 2.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 1.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.5 | 11.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.5 | 5.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 2.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.5 | 2.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.5 | 3.5 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.5 | 1.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 2.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.5 | 2.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.5 | 9.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.5 | 8.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 13.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 1.4 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.5 | 0.5 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.5 | 1.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.5 | 5.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 8.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.5 | 2.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 0.5 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.5 | 5.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 0.9 | GO:1904464 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
0.4 | 0.4 | GO:2000872 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) positive regulation of progesterone secretion(GO:2000872) |
0.4 | 5.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.4 | 2.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.4 | 8.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 2.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.4 | 1.3 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
0.4 | 1.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 1.3 | GO:0051030 | snRNA transport(GO:0051030) |
0.4 | 1.7 | GO:1903542 | lipophagy(GO:0061724) negative regulation of exosomal secretion(GO:1903542) |
0.4 | 1.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.4 | 1.3 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.4 | 2.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.4 | 1.3 | GO:0035553 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
0.4 | 1.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 2.5 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 4.2 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.4 | 2.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 2.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 2.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 1.6 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 2.0 | GO:1903071 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.4 | 3.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 2.4 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 2.8 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.4 | 4.8 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 2.8 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.4 | 0.8 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.4 | 5.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 3.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 1.2 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.4 | 1.6 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 3.5 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.4 | 2.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 2.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.9 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 2.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 8.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 1.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 3.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.4 | 2.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.4 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.5 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 2.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 6.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 3.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 2.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 2.5 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.4 | 7.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.4 | 3.2 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 1.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 1.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.4 | 1.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.4 | 2.1 | GO:1990839 | response to endothelin(GO:1990839) |
0.3 | 4.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 3.1 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.3 | 3.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 3.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.3 | 7.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 5.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 1.0 | GO:0097184 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
0.3 | 7.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 3.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 6.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.3 | 1.0 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.3 | 2.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 1.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 0.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 2.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 1.6 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.3 | 1.3 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.3 | 1.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.6 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.3 | 10.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 4.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 1.6 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 1.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 2.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 2.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 4.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 1.5 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 1.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 2.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 0.9 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.3 | 5.6 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.3 | 0.9 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.3 | 1.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 4.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.9 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.3 | 1.1 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.3 | 1.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 3.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 1.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.3 | 1.1 | GO:0000239 | pachytene(GO:0000239) |
0.3 | 2.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 1.9 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 13.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.3 | 1.9 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 1.4 | GO:0060523 | Sertoli cell proliferation(GO:0060011) prostate epithelial cord elongation(GO:0060523) |
0.3 | 1.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 0.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.3 | 3.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.3 | 1.1 | GO:1902477 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.3 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
0.3 | 1.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 12.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 4.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.3 | 1.8 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.3 | 2.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 3.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 2.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 1.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 3.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 1.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 3.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 3.7 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.2 | 2.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 3.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 14.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 7.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 2.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.5 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.2 | 1.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.9 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.2 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.7 | GO:0098923 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) trans-synaptic signaling by soluble gas(GO:0099543) |
0.2 | 0.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 5.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 1.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 0.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.9 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) response to selenium ion(GO:0010269) |
0.2 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 4.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0072679 | thymocyte migration(GO:0072679) |
0.2 | 3.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 3.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.6 | GO:1900062 | regulation of replicative cell aging(GO:1900062) |
0.2 | 1.9 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 3.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 4.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.8 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 2.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.6 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 0.6 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 2.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 3.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 5.7 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.2 | 3.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.4 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.6 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.2 | 3.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 2.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.6 | GO:0060466 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
0.2 | 0.7 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.2 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.2 | 0.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.2 | 3.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.7 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 1.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 2.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 0.9 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 0.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 1.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 21.1 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 12.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 1.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 3.5 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 0.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.2 | 0.5 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.2 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.2 | 5.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 2.0 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.5 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.2 | 1.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.5 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 1.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 2.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 1.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 4.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 3.5 | GO:0042311 | vasodilation(GO:0042311) |
0.2 | 0.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 0.6 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 2.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 2.3 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.3 | GO:1990927 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 2.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 2.2 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 1.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 1.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 2.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 6.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 2.6 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 3.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 1.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 13.6 | GO:0007586 | digestion(GO:0007586) |
0.1 | 4.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.6 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 4.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 2.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 2.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 1.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 2.5 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 2.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.9 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.1 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
0.1 | 0.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 1.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 7.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 1.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.2 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 3.6 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.6 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 3.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.4 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 1.0 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 1.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 3.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 1.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.6 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 1.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.9 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 1.9 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 2.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 1.1 | GO:0060484 | positive regulation of activin receptor signaling pathway(GO:0032927) lung-associated mesenchyme development(GO:0060484) |
0.1 | 1.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 1.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.9 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 1.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.6 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.9 | GO:0061709 | reticulophagy(GO:0061709) |
0.1 | 0.5 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 4.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.7 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.1 | 6.8 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.5 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 1.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.7 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 1.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 1.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:1902739 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.3 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 0.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 1.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 8.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 4.2 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.1 | 1.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 1.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 2.4 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 1.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.4 | GO:0043056 | forward locomotion(GO:0043056) |
0.1 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 1.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.5 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.1 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 1.9 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 3.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.3 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.5 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) positive regulation of T cell migration(GO:2000406) |
0.1 | 1.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 1.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.1 | 11.9 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.3 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.0 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 2.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 1.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.6 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 2.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.7 | GO:0060974 | cell migration involved in heart formation(GO:0060974) |
0.1 | 2.5 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 2.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.2 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.1 | 1.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.1 | 2.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 2.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 2.8 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 1.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 2.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 2.8 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 3.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0060931 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.1 | 0.6 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 1.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 1.2 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.3 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.8 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 2.8 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 1.9 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 1.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.6 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 1.8 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 2.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 1.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 2.0 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.6 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.4 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.3 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 1.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 2.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.6 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 2.1 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.7 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 2.5 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.5 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.3 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
0.0 | 0.8 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 1.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 1.0 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 4.1 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 1.8 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.7 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.6 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.3 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.0 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.6 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.0 | 0.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.4 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.9 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.0 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.0 | 0.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.0 | 0.1 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.0 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.0 | 0.2 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 121.4 | GO:0042627 | chylomicron(GO:0042627) |
4.9 | 14.8 | GO:0044317 | rod spherule(GO:0044317) |
3.9 | 39.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
2.9 | 37.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.4 | 2.4 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
2.0 | 8.1 | GO:0097447 | dendritic tree(GO:0097447) |
1.9 | 28.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.7 | 15.5 | GO:0005579 | membrane attack complex(GO:0005579) |
1.7 | 12.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.5 | 5.9 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
1.4 | 12.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.4 | 5.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.4 | 16.4 | GO:0045275 | respiratory chain complex III(GO:0045275) |
1.2 | 3.6 | GO:0061474 | phagolysosome membrane(GO:0061474) |
1.2 | 3.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
1.1 | 3.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
1.1 | 11.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.1 | 13.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.1 | 6.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 3.5 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.8 | 8.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.8 | 8.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 2.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.8 | 2.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.7 | 19.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.7 | 3.6 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.7 | 11.9 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 2.8 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.7 | 2.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 6.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 34.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 1.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 2.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.6 | 1.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.6 | 3.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 4.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.6 | 2.8 | GO:0000802 | transverse filament(GO:0000802) |
0.6 | 9.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 16.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.5 | 9.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 1.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 3.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 2.0 | GO:1990037 | Lewy body core(GO:1990037) |
0.5 | 1.5 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.5 | 6.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 2.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.5 | 14.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.5 | 3.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 86.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 2.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 4.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.8 | GO:0034683 | integrin alphav-beta3 complex(GO:0034683) integrin alphav-beta8 complex(GO:0034686) |
0.4 | 2.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 2.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 2.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 0.4 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.4 | 4.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 6.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 100.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 1.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.4 | 1.9 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 1.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 4.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 1.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 2.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 1.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 5.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 0.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.3 | 3.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 14.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 5.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 2.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 5.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 0.5 | GO:0071914 | prominosome(GO:0071914) |
0.2 | 9.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 8.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 2.4 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.9 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.4 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 1.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 1.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.9 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.2 | 12.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 2.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 1.6 | GO:0001652 | granular component(GO:0001652) |
0.2 | 4.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.8 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 2.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 6.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 2.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 1.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 4.5 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 8.7 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 3.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 10.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 3.4 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 3.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 4.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 4.4 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.9 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 0.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.0 | GO:0031968 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.2 | 79.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 2.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 3.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.5 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 1.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 59.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.5 | GO:0016014 | dystrobrevin complex(GO:0016014) |
0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 3.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 1.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 2.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 236.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 2.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 2.8 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 4.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.4 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 3.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.6 | GO:0030127 | ER to Golgi transport vesicle membrane(GO:0012507) COPII vesicle coat(GO:0030127) |
0.1 | 0.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 2.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.3 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.1 | 124.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 2.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.1 | 2.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 7.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 2.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 2.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0070992 | translation initiation complex(GO:0070992) |
0.1 | 3.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 2.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 1.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 1.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 4.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.0 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 60.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.6 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 4.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 2.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.0 | GO:0097433 | dense body(GO:0097433) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.2 | 20.5 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
9.5 | 57.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
8.4 | 42.1 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
8.2 | 32.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
7.2 | 50.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
5.9 | 17.6 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
5.6 | 27.9 | GO:0005186 | pheromone activity(GO:0005186) |
5.2 | 26.2 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
5.0 | 15.1 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
4.8 | 28.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
4.7 | 18.8 | GO:0019862 | IgA binding(GO:0019862) |
4.7 | 18.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
4.6 | 18.3 | GO:0042806 | fucose binding(GO:0042806) |
4.5 | 17.8 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
4.4 | 13.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
4.4 | 17.5 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
4.3 | 17.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
3.9 | 11.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
3.9 | 11.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
3.6 | 10.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
3.6 | 14.5 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
3.6 | 14.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.3 | 9.8 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
3.2 | 15.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
3.0 | 9.1 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
3.0 | 18.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
2.9 | 11.6 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
2.7 | 19.0 | GO:0001851 | complement component C3b binding(GO:0001851) |
2.7 | 10.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.6 | 15.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
2.6 | 15.4 | GO:0004359 | glutaminase activity(GO:0004359) |
2.5 | 15.2 | GO:0015232 | heme transporter activity(GO:0015232) |
2.5 | 12.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
2.3 | 9.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
2.3 | 6.8 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
2.3 | 6.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
2.2 | 13.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
2.2 | 15.6 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
2.2 | 62.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.2 | 8.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
2.2 | 13.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.1 | 6.4 | GO:0016662 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
2.1 | 17.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
2.1 | 6.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.1 | 6.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
2.1 | 12.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.0 | 16.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
2.0 | 5.9 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.9 | 5.8 | GO:0070279 | vitamin B6 binding(GO:0070279) |
1.8 | 5.5 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
1.8 | 7.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.7 | 13.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.7 | 41.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.7 | 5.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.7 | 28.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.6 | 11.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.5 | 4.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.5 | 6.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.5 | 4.5 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
1.5 | 11.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.5 | 7.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.5 | 5.9 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
1.4 | 4.3 | GO:0008431 | vitamin E binding(GO:0008431) |
1.4 | 5.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.4 | 4.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.3 | 6.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.3 | 4.0 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.3 | 4.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.3 | 4.0 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) |
1.3 | 3.8 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) uniporter activity(GO:0015292) |
1.3 | 3.8 | GO:0070404 | NADH binding(GO:0070404) |
1.3 | 5.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.2 | 6.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.2 | 39.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.2 | 4.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.2 | 48.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.2 | 13.9 | GO:0001846 | opsonin binding(GO:0001846) |
1.1 | 7.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.1 | 3.4 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
1.1 | 2.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.1 | 3.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.1 | 4.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.1 | 2.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.1 | 4.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.1 | 4.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
1.1 | 4.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.0 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 6.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.0 | 10.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.0 | 9.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.0 | 9.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 5.9 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
1.0 | 2.9 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
1.0 | 2.9 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.0 | 3.9 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
1.0 | 5.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.0 | 6.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.0 | 6.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.0 | 2.9 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.9 | 3.8 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.9 | 2.8 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.9 | 4.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.9 | 3.7 | GO:0050436 | microfibril binding(GO:0050436) |
0.9 | 2.8 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.9 | 3.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.9 | 3.7 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.9 | 8.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.9 | 7.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.9 | 24.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.8 | 1.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.8 | 7.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 4.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 4.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.8 | 13.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.8 | 4.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.8 | 2.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.8 | 9.4 | GO:0001848 | complement binding(GO:0001848) |
0.8 | 12.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.8 | 4.6 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.8 | 5.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.7 | 4.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 3.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 7.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 3.0 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.7 | 8.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.7 | 8.1 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 3.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.7 | 3.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 2.2 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.7 | 2.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.7 | 15.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.7 | 8.3 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.7 | 2.0 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.7 | 2.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.7 | 4.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 7.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 2.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.7 | 3.3 | GO:0047804 | cysteine-S-conjugate beta-lyase activity(GO:0047804) |
0.7 | 2.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.7 | 5.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 1.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.6 | 0.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 2.5 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.6 | 3.8 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.6 | 1.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.6 | 8.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 2.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.6 | 2.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.6 | 2.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.6 | 3.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 12.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 3.5 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.6 | 2.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.6 | 2.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.6 | 2.3 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.6 | 6.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 14.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 1.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.6 | 2.8 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.6 | 7.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.6 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.5 | 4.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 2.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.6 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.5 | 2.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.5 | 2.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 9.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 2.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.5 | 1.5 | GO:0034012 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
0.5 | 26.4 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 1.9 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.5 | 11.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.5 | 4.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 2.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.5 | 4.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 1.9 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.5 | 1.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 1.8 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.5 | 3.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 3.2 | GO:0045174 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.5 | 8.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 3.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 7.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 13.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 3.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 10.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 5.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 3.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 1.3 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.4 | 12.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 3.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.4 | 6.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 2.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 4.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.4 | 56.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 4.0 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 2.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 4.8 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 2.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 1.2 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.4 | 5.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 3.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 3.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 6.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 3.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 0.8 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.4 | 2.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 3.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.4 | 2.2 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.8 | GO:0043546 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 5.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 7.2 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 1.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 1.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 2.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 5.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.7 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.3 | 3.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.0 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.3 | 2.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 2.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 2.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 2.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 2.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 5.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 3.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 2.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 2.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 0.9 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 4.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 1.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 0.9 | GO:0047237 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.3 | 0.9 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.3 | 1.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 0.9 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.3 | 1.5 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 1.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 2.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 4.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 7.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 7.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 7.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 1.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 19.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 2.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 5.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 30.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.3 | 1.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 5.5 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 1.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.3 | 1.6 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 6.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 2.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 3.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 1.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 0.8 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.3 | 16.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.3 | 1.0 | GO:0051381 | histamine binding(GO:0051381) |
0.3 | 1.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 22.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 6.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 1.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 2.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 5.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 4.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 6.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 4.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.7 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.2 | 4.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 0.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 7.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 5.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 9.8 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 2.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 9.6 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.2 | 1.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.0 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 5.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 9.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 8.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 3.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 15.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 4.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 3.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 3.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.5 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.2 | 16.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 1.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 7.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 6.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 1.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) L-malate dehydrogenase activity(GO:0030060) |
0.1 | 1.0 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 1.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.7 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 2.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 5.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.4 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 10.7 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 1.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.4 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.1 | 4.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 1.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.9 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 1.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 8.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 23.0 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 2.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 2.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 3.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.4 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.1 | 3.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0033797 | selenate reductase activity(GO:0033797) |
0.1 | 0.3 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.1 | 0.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.3 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 9.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 2.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 1.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 3.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 1.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 8.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.1 | 2.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 4.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 1.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 3.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 2.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 1.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 1.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 1.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 1.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 3.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) phosphofructokinase activity(GO:0008443) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 1.2 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 3.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 17.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 29.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 34.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 116.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 3.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 19.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 3.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 3.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.0 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 11.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 4.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 12.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 10.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 10.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 4.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 5.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 4.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 2.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 4.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.5 | 10.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.3 | 95.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.8 | 38.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.1 | 22.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
2.0 | 28.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.9 | 55.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.6 | 41.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.5 | 20.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.2 | 20.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.0 | 29.6 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
1.0 | 22.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 18.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.9 | 11.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.8 | 9.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 13.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.8 | 58.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.7 | 15.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 11.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 154.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.6 | 5.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 45.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.5 | 6.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 15.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 5.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 2.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 4.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 3.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 6.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 1.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 3.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.4 | 0.8 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.4 | 1.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.4 | 13.6 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.4 | 2.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.4 | 4.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 11.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 8.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 7.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 23.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 2.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 5.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 2.9 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 3.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 5.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 5.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 4.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 8.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 3.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 3.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 23.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 5.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 4.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 5.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 6.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 3.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 5.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 3.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 3.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 3.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.3 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 1.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 3.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 2.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 4.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 9.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.8 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 1.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 3.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 2.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 1.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |